Stock Analiz

AtriCure, Inc. (ATRC) stock forecast and price target

Price $56.84 · data as of November 13, 2026

12-month price target

Average target$64.89
Upside / downside+14.2%
Analysts9
ConsensusBuy
Low $50.00Average $64.89High $70.00

Gold marker: average target · white marker: today’s price ($56.84)

Analyst ratings

Strong buy 3Buy 4Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$0.43+488.0%$608M
Next fiscal year
ends December 31, 2027
$0.46+7.8%$682M
Next quarter
ends December 31, 2026
$0.07+14.1%$160M
Quarter after
ends March 31, 2027
$0.03+0.0%$159M

Consensus of the analysts covering AtriCure, updated daily. In the last 30 days 6 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 14.2% upside over 12 months. Our discounted cash flow model with moderate assumptions puts AtriCure’s intrinsic value about 92% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the AtriCure stock price target?

The average 12-month target from 9 analysts is $64.89, 14.2% above the current price of $56.84 Targets range from $50.00 to $70.00.

Is AtriCure a buy according to analysts?

The consensus rating is “Buy” (3 strong buy, 4 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is AtriCure expected to earn?

Analysts expect EPS of $0.43 for the fiscal year ending December 31, 2026 and $0.46 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.